If you have been on semaglutide or tirzepatide for more than a year, expect a longer and more gradual taper, potentially 12 weeks or more instead of 9
Victoza (liraglutide), the first GLP-1 for type 2 diabetes to lose exclusivity in June 2024, may not generate significant savings due to its once-daily dosing and limited market share
By using GLP-1 injections, we can enhance these natural signals, making you feel fuller sooner and helping reduce cravings
Hypertension High Cholesterol Type 2 Diabetes Obstructive Sleep Apnea Cardiovascular Disease It is not advisable for patients to take this medication if any of the following apply: Insulin users Type 1 Diabetes Mellitus (Insulin Dependent) diagnosis History of Diabetic Retinopathy Personal or family history of Medullary Thyroid Cancer or Multiple Endocrine Neoplasia Syndrome Type 2 (MEN 2) Personal or family history of pancreatitis, or certain liver or kidney problems Allergy to medication being administered Pregnant or breastfeeding individuals Previous history of an eating disorder BMI less than 18.5 Under 18 years of age Nausea Diarrhea Vomiting Constipation Abdominal pain Increased heart rate Headache Congestion Fatigue Indigestion Dizziness From day one, we provide comprehensive, compassionate support to help you feel empowered
Adopt a versatile option
Each one delivers high-protein, macro-complete smoothies packed with healthy fats, vitamin B12, fibre, and antioxidants